WASHINGTON, DC - The Subcommittee on Oversight and Investigations, chaired by Rep. Gregg Harper (R-MS), announced a hearing for Tuesday, July 24, at 10 a.m. in room 2123 of the Rayburn House Office Building. The hearing is entitled, “Examining Advertising and Marketing Practices within the Substance Use Treatment Industry."
Building off the committee’s bipartisan ongoing investigation into patient brokering, which began one year ago, #SubOversight will examine practices within the substance use treatment industry, including advertising and marketing practices.
“As we dig deeper into the industry’s marketing and advertising practices, it’s important we also review and discuss what quality treatment looks like, so patients and their families are better equipped with information about what they should look for when seeking treatment for themselves or a loved one," said #SubOversight Chairman Harper. “There has been a heightened demand for treatment during the opioid crisis, but with it has come additional concerns about treatment facilities’ marketing and advertising practices, as well as the quality of care patients receive."
In May, bipartisan committee leaders questioned a series of companies about their business practices and requested information about how they market and advertise in the substance use treatment industry, including information about call centers and websites, how their employees are trained, and what they disclose to callers about any affiliations with treatment centers. #SubOversight held its first hearing examining patient brokering in December 2017.as they are posted.
